Health Care Market News Psychedelics MindBio’s microdosed LSD reduces depression post treatment MindBio (CSE:MBIO), a psychedelic healthcare stock, reports a sustained 65% reduction in depressive symptoms in its phase 2A clinical trial. Trevor Abes2 mins20 June 2024 09:25 (EDT)
Health Care Market News Psychedelics Optimi Health completes first MDMA shipment to Israel Optimi Health (CSE:OPTI) recently touted several milestones it had achieved in its international psychedelic supply operations strategy. Jonathon Brown2 mins11 June 2024 11:20 (EDT)
Market News Psychedelics Red Light Holland completes psilocybin extraction report Red Light Holland (CSE:TRIP) reveals it has successfully completed the comprehensive extraction protocol with PharmAla Biotech (CSE:MDMA). Jocelyn Aspa2 mins07 June 2024 13:33 (EDT)
Health Care Market News Psychedelics FDA committee rejects MDMA drug, discounting psychedelic stocks A committee of the U.S. FDA rejects a drug application to treat PTSD using MDMA-assisted therapy, causing numerous stocks to fall. Trevor Abes4 mins07 June 2024 10:37 (EDT)
Market News Psychedelics Sponsored Record monthly revenue positions edibles company for success Canadian cannabis edibles are generating traction and Indiva (TSXV:NDVA) remains poised to capitalize on this ever-growing industry. Jocelyn Aspa3 mins05 June 2024 07:00 (EDT)
Health Care Market News Psychedelics Optimi Health cleared to supply MDMA and psilocybin worldwide Optimi Health (CSE:OPTI) earns a Health Canada Drug Establishment Licence to produce and sell its MDMA and psilocybin capsules in Australia. Trevor Abes2 mins04 June 2024 08:59 (EDT)
Health Care Market News Psychedelics Numinus approved for pioneering MDMA-based clinical trial Numinus Wellness (TSX:NUMI) receives Health Canada approval for a clinical trial examining group models in MDMA-assisted psychotherapy. Trevor Abes3 mins30 May 2024 09:05 (EDT)
Market News Psychedelics Red Light Holland and PharmAla notch psilocybin extraction Red Light Holland (CSE:TRIP) reveals it has successfully completed the first phase of psilocybin extraction to PharmAla Biotech (CSE:MDMA). Jocelyn Aspa2 mins27 May 2024 12:49 (EDT)
Market News Psychedelics Optimi Health to advance psychedelic clinical trials Optimi Health (CSE:OPTI) signs letter of intent with ATMA Journey Centers to advance its psilocybin extract into a psilocybin clinical trial. Jocelyn Aspa2 mins22 May 2024 12:57 (EDT)
Market News Psychedelics Optimi Health certified for increased MDMA capsule dosages Optimi Health (CSE:OPTI) confirms its formulated MDMA meets Good Manufacturing Practice specifications after third-party laboratory testing. Jonathon Brown2 mins14 May 2024 08:56 (EDT)
Health Care Market News Psychedelics Optimi Health makes first international MDMA shipment Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University. Jocelyn Aspa2 mins09 May 2024 13:40 (EDT)
Market News Psychedelics Red Light Holland and Costco Canada partner on mushroom kits Red Light Holland (CSE:TRIP) partners with Costco Canada to launch Mega Block, a 2-kilogram home-grow mushroom kit, in late May. Jocelyn Aspa2 mins06 May 2024 12:45 (EDT)
Market News Psychedelics CCrest Labs receives Red Light Holland’s largest psilocybin order Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal. Jocelyn Aspa2 mins12 April 2024 13:03 (EDT)
Health Care Market News Psychedelics Red Light Holland reports record psilocybin shipment Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal. Trevor Abes3 mins09 April 2024 11:14 (EDT)
Market News Psychedelics Psychedelic stock begins take-home LSD microdosing clinical trial MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial. Jonathon Brown2 mins20 March 2024 10:36 (EDT)
Market News Psychedelics Red Light Holland begins experimental research on psilocybin truffles Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles. Jocelyn Aspa2 mins08 March 2024 13:27 (EDT)
Health Care Market News Psychedelics Psychedelic stock clears hurdle to treating depression with LSD Psychedelic stock MindBio (CSE:MBIO) is revealing positive top-line data from its pioneering microdosing clinical trial to treat depression. Trevor Abes2 mins26 February 2024 09:03 (EDT)
Health Care Market News Psychedelics Clearmind Medicine to begin alcohol use disorder clinical trial Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel. Jocelyn Aspa2 mins23 February 2024 12:05 (EDT)
Market News Psychedelics Red Light Holland and PharmAla to collaborate on medical psilocybin Red Light Holland (CSE:TRIP) has entered into a collaboration with PharmAla Biotech Holdings (CSE:MDMA) for medical psilocybin. Jocelyn Aspa2 mins09 February 2024 14:34 (EDT)
Economy Health Care Psychedelics Sponsored Numinus Wellness offers turnkey exposure to psychedelic medicine Stock investors searching for holistic exposure to psychedelic medicine should add Numinus Wellness to their due diligence lists. Trevor Abes6 mins29 January 2024 07:00 (EDT)